Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference …

EM Meima-van Praag, KL van Rijn… - The Lancet …, 2022 - thelancet.com
Summary Background Guidelines on Crohn's perianal fistulas recommend anti-tumour
necrosis factor (TNF) treatment and suggest considering surgical closure for patients with …

Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference …

EM Meima-van Praag, KL van Rijn, KA Wasmann… - 2022 - pubmed.ncbi.nlm.nih.gov
Background Guidelines on Crohn's perianal fistulas recommend anti-tumour necrosis factor
(TNF) treatment and suggest considering surgical closure for patients with surgically …

Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference …

EM Meima-van Praag, KL van Rijn… - The Lancet …, 2022 - thelancet.com
Summary Background Guidelines on Crohn's perianal fistulas recommend anti-tumour
necrosis factor (TNF) treatment and suggest considering surgical closure for patients with …

Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference …

EM Meima-van Praag… - The Lancet …, 2022 - researchinformation.amsterdamumc …
Background: Guidelines on Crohn's perianal fistulas recommend anti-tumour necrosis factor
(TNF) treatment and suggest considering surgical closure for patients with surgically …

Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference …

EM Meima-van Praag, KL van Rijn… - The Lancet …, 2022 - Elsevier
Summary Background Guidelines on Crohn's perianal fistulas recommend anti-tumour
necrosis factor (TNF) treatment and suggest considering surgical closure for patients with …

Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference …

EM Meima-van Praag, KL van Rijn… - The lancet …, 2022 - europepmc.org
Background Guidelines on Crohn's perianal fistulas recommend anti-tumour necrosis factor
(TNF) treatment and suggest considering surgical closure for patients with surgically …